There is much debate worldwide over how governmental policies affect pharmaceutical innovation. Ensuring the safety of drugs must be offset against providing timely access to potentially life-saving or life-enhancing therapies. The authors argue that there is a need for a more balanced approach to governmental interventions.
Patent protections, pricing freedom, and the ability to market new products have given the United States the most innovative pharmaceutical industry on earth. Why we must resist new efforts to regulate Big Pharma. By Richard A. Epstein.
The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.